Company / Shares Outstanding
BridgeBio Pharma, Inc. Shares Outstanding History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
190.0M
FY2025
5-year range
122.8M / 190.0M
FY2021-FY2025
Trend
+8.5%
vs FY2024
Sector context
#46 of 212
Health Care
What the data says
BridgeBio Pharma, Inc.'s shares outstanding of 190044473.00 is higher than 78% of companies in the Health Care sector (FY2025). Shares Outstanding has increased for 4 consecutive years, from 122849389.00 in FY2021 to 190044473.00 in FY2025.
Based on SEC 10-K filings.
190044473.00 in FY2025 with a 5-year CAGR of +9.0%. Top quartile in the Health Care sector.
Increased from 150625572.00 to 190044473.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +8.9%
- 5-Year CAGR
- +9.0%
- 10-Year CAGR
- -
Sector benchmark
-37.9% below sector average
Key checks
Key Insights
- BridgeBio Pharma, Inc.'s shares outstanding has grown for 4 consecutive years.
- In FY2025, shares outstanding increased 8.5% year-over-year.
- Ranks #46 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 190.0M | +8.5% |
| FY2024 | 175.1M | +16.2% |
| FY2023 | 150.6M | +2.2% |
| FY2022 | 147.3M | +19.9% |
| FY2021 | 122.8M | -0.7% |
| FY2020 | 123.7M | +34.3% |
| FY2019 | 92.1M | +49.0% |
| FY2018 | 61.8M | +101.9% |
| FY2017 | 30.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026